Corticosteroid-related Central Nervous System Side Effects

Overview

Journal J Pharmacol Pharmacother

Specialty Pharmacology

Date 2013 Dec 19

PMID 24347992

Citations 79

Authors

Miriam Ciriaco

Pasquale Ventrice

Gaetano Russo

Maria Scicchitano

Giovanni Mazzitello

Francesca Scicchitano

Emilio Russo

Affiliations

Soon will be listed here.

Abstract

Corticosteroids have been used since the 50s as anti-inflammatory and immunosuppressive drugs for the treatment of several pathologies such as asthma, allergy, rheumatoid arthritis, and dermatological disorders. Corticosteroids have three principal mechanisms of action: 1) inhibit the synthesis of inflammatory proteins blocking NF-kB, 2) induce the expression of anti-inflammatory proteins by IkB and MAPK phosphatase I, and 3) inhibit 5-lipoxygenase and cyclooxygenase-2. The efficacy of glucocorticoids in alleviating inflammatory disorders results from the pleiotropic effects of the glucocorticoid receptors on multiple signaling pathways. However, they have adverse effects: Growth retardation in children, immunosuppression, hypertension, hyperglycemia, inhibition of wound repair, osteoporosis, metabolic disturbances, glaucoma, and cataracts. Less is known about psychiatric or side effects on central nervous system, as catatonia, decreased concentration, agitation, insomnia, and abnormal behaviors, which are also often underestimated in clinical practice. The aim of this review is to highlight the correlation between the administration of corticosteroids and CNS adverse effects, giving a useful guide for prescribers including a more careful assessment of risk factors and encourage the use of safer doses of this class of drugs.

Citing Articles

Mechanisms and Emerging Regulators of Neuroinflammation: Exploring New Therapeutic Strategies for Neurological Disorders.

Kim M, Lee J Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852123 PMC: 11763386. DOI: 10.3390/cimb47010008.

Omega-3 Polyunsaturated Fatty Acids in Chronic Obstructive Pulmonary Disease Patients with COVID-19: A Review.

Zailani H, Satyanarayanan S, Liao W, Su K, Chang J Curr Nutr Rep. 2025; 14(1):12.

PMID: 39760917 DOI: 10.1007/s13668-024-00599-9.

Oleic acid attenuates asthma pathogenesis via Th1/Th2 immune cell modulation, TLR3/4-NF-κB-related inflammation suppression, and intrinsic apoptotic pathway induction.

Lee S, Le D, Bae C, Park J, Lee M, Cho S Front Immunol. 2024; 15:1429591.

PMID: 39421735 PMC: 11484255. DOI: 10.3389/fimmu.2024.1429591.

Molecular, Pathophysiological, and Clinical Aspects of Corticosteroid-Induced Neuropsychiatric Effects: From Bench to Bedside.

Sofia-Avendano-Lopez S, Rodriguez-Marin A, Lara-Castillo M, Agresott-Carrillo J, Lara-Cortes L, Sanchez-Almanzar J Biomedicines. 2024; 12(9).

PMID: 39335644 PMC: 11429036. DOI: 10.3390/biomedicines12092131.

Risk of neuropsychiatric adverse events associated with montelukast use in children and adolescents: a population-based case-crossover study.

Kim J, Kim M, Seo M, Shin J BMJ Paediatr Open. 2024; 8(1.

PMID: 39251365 PMC: 11733910. DOI: 10.1136/bmjpo-2023-002483.

References

Coluccia D, Wolf O, Kollias S, Roozendaal B, Forster A, de Quervain D . Glucocorticoid therapy-induced memory deficits: acute versus chronic effects. J Neurosci. 2008; 28(13):3474-8. PMC: 6670588. DOI: 10.1523/JNEUROSCI.4893-07.2008. View

Fardet L, Petersen I, Nazareth I . Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry. 2012; 169(5):491-7. DOI: 10.1176/appi.ajp.2011.11071009. View

Da Silva J, Jacobs J, Kirwan J, Boers M, Saag K, Ines L . Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2005; 65(3):285-93. PMC: 1798053. DOI: 10.1136/ard.2005.038638. View

Robinson D, Harrison-Hansley E, Spencer R . Steroid psychosis after an intra-articular injection. Ann Rheum Dis. 2001; 59(11):927. PMC: 1753035. DOI: 10.1136/ard.59.11.926a. View

George M, Sharma V, Jacobson J, Simon S, Nopper A . Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol. 2004; 140(8):963-9. DOI: 10.1001/archderm.140.8.963. View

Bolanos S, Khan D, Hanczyc M, Bauer M, Dhanani N, Brown E . Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol. 2004; 92(5):500-5. DOI: 10.1016/S1081-1206(10)61756-5. View

Fietta P, Fietta P, Delsante G . Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci. 2009; 63(5):613-22. DOI: 10.1111/j.1440-1819.2009.02005.x. View

Hall R, Popkin M, Kirkpatrick B . Tricyclic exacerbation of steroid psychosis. J Nerv Ment Dis. 1978; 166(10):738-42. View

Bender B, Lerner J, Kollasch E . Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry. 1988; 27(6):720-5. DOI: 10.1097/00004583-198811000-00010. View

10.

Curtis J, Westfall A, Allison J, Bijlsma J, Freeman A, George V . Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006; 55(3):420-6. DOI: 10.1002/art.21984. View

11.

Kahn D, Stevenson E, Douglas C . Effect of sodium valproate in three patients with organic brain syndromes. Am J Psychiatry. 1988; 145(8):1010-1. DOI: 10.1176/ajp.145.8.1010. View

12.

Lewis D, Smith R . Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord. 1983; 5(4):319-32. DOI: 10.1016/0165-0327(83)90022-8. View

13.

Duma D, Jewell C, Cidlowski J . Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol. 2006; 102(1-5):11-21. DOI: 10.1016/j.jsbmb.2006.09.009. View

14.

. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther. 1972; 13(5):694-8. DOI: 10.1002/cpt1972135part1694. View

15.

Sapolsky R, Romero L, Munck A . How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000; 21(1):55-89. DOI: 10.1210/edrv.21.1.0389. View

16.

McEwen B . Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity. Neurochem Res. 2000; 25(9-10):1219-31. DOI: 10.1023/a:1007687911139. View

17.

Ioannou N, Liapi C, Sekeris C, Palaiologos G . Effects of dexamethasone on K(+)-evoked glutamate release from rat hippocampal slices. Neurochem Res. 2003; 28(6):875-81. DOI: 10.1023/a:1023271325728. View

18.

Schacke H, Docke W, Asadullah K . Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002; 96(1):23-43. DOI: 10.1016/s0163-7258(02)00297-8. View

19.

Lewis G, Jusko W, Graves L, BURKE C . Prednisone side-effects and serum-protein levels. A collaborative study. Lancet. 1971; 2(7728):778-80. DOI: 10.1016/s0140-6736(71)92738-3. View

20.

Wada K, Yamada N, Sato T, Suzuki H, Miki M, Lee Y . Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics. 2002; 42(6):461-6. DOI: 10.1176/appi.psy.42.6.461. View